Friedman H
Immunology. 1975 Aug;29(2):283-99.
Antibody plaque-forming cells (FC) to the somatic antigens of Vibrio cholerae were enumerated in the spleen of mice after primary and secondary immunization with a heat-killed vaccine prepared from the vibrios. Immunocytes releasing both high efficiency IgM and low efficiency IgG antibody were readily detected using a direct and facilitated plaque procedure in agar gel. Whereas the peak numbers of IgM-PFC after primary immunization occurred on days 12 to 14, the peak IgG-PFC response developed somewhat later (16-18 days). After a second injection of vaccine larger numbers of both IgM- and IgG-PFE appeared in the mouse spleens, with peak responses for both occurring between days 5 and 8. The largest number of IgG-PFC developed in spleens of mice given a second injection of vaccine 6-8 weeks after primary immunization. The dose of killed vibrios used for priming markedly affected both the magnitude and the class of antibody-forming cells appearing during the secondary response; 1--10 mug vaccine was more effective than higher or lower doses for priming the mice to a heightened secondary response. Furthermore, the antigenic specificity of both the IgM- and IgG-PFC appearing after secondary immunization was directly related to the strain of cholera bacilli used for priming. When mice were immunized with the Ogawa strains of cholera most of the secondary PFC after booster immunization with the serologically distinct Inaba strain was directed towards the common antigen shared by both strains and not to the type specific antigen of the Inaba vibrios. The specificity of the anti-vibrio PFC during both the primary and secondary responses was readily demonstrable by inhibition experiments using sonicated or soluble cholera antigens. Prior incubation of these antigens with test spleen cells in the agar gel effictively inhibited development of the vibriolytic plaques, regardless of antibody class. Similar antigen extracts from toher bacteria had no effect. The immunoglobulin nature of the plaques was also demonstrable by inhibition with low dilutions of rabbit anti-mouse globulin serum incorporated into the agar plates prior to testing; both IgM and IgG plaues were inhibited.
在用霍乱弧菌制备的热灭活疫苗对小鼠进行初次和二次免疫后,测定小鼠脾脏中针对霍乱弧菌菌体抗原的抗体噬斑形成细胞(FC)。使用琼脂凝胶中的直接和简易噬斑法,很容易检测到释放高效IgM和低效IgG抗体的免疫细胞。初次免疫后,IgM-PFC的峰值出现在第12至14天,而IgG-PFC的峰值反应出现得稍晚(16 - 18天)。第二次注射疫苗后,小鼠脾脏中出现了更多的IgM-和IgG-PFE,两者的峰值反应都出现在第5至8天之间。在初次免疫后6 - 8周接受第二次疫苗注射的小鼠脾脏中,IgG-PFC的数量最多。用于初次免疫的灭活弧菌剂量显著影响二次反应中出现的抗体形成细胞的数量和类别;1 - 10微克疫苗比更高或更低剂量更有效地使小鼠产生增强的二次反应。此外,二次免疫后出现 的IgM-和IgG-PFC的抗原特异性与用于初次免疫的霍乱杆菌菌株直接相关。当用小川型霍乱菌株免疫小鼠时,在用血清学上不同的稻叶型菌株进行加强免疫后,大多数二次PFC针对的是两种菌株共有的共同抗原,而不是稻叶型弧菌的型特异性抗原。在初次和二次反应期间,抗弧菌PFC的特异性可以通过使用超声处理的或可溶性霍乱抗原的抑制实验很容易地证明。在琼脂凝胶中,这些抗原与测试脾细胞预先孵育可有效抑制溶菌噬斑的形成,无论抗体类别如何。来自其他细菌的类似抗原提取物没有效果。噬斑的免疫球蛋白性质也可以通过在测试前将低稀释度的兔抗小鼠球蛋白血清掺入琼脂平板中进行抑制来证明;IgM和IgG噬斑均被抑制。